Sale!

APTX Gene Ataxia-Oculomotor Apraxia Type 1 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The APTX Gene Ataxia-Oculomotor Apraxia Type 1 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the APTX gene responsible for this rare neurological disorder. Using Next-Generation Sequencing technology, this test provides comprehensive analysis of the APTX gene to detect pathogenic variants associated with ataxia-oculomotor apraxia type 1 (AOA1). The test is crucial for individuals experiencing progressive coordination difficulties, eye movement abnormalities, and neurological symptoms. Early genetic diagnosis enables proper management, family planning decisions, and targeted therapeutic approaches. Results are typically available within 3-4 weeks from blood or DNA samples. This comprehensive genetic analysis is available for $500 USD, offering significant savings from the regular $700 price.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

APTX Gene Ataxia-Oculomotor Apraxia Type 1 NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The APTX Gene Ataxia-Oculomotor Apraxia Type 1 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, providing precise identification of mutations in the APTX gene associated with this rare inherited condition. Ataxia-oculomotor apraxia type 1 (AOA1) is an autosomal recessive neurodegenerative disorder characterized by progressive cerebellar ataxia, oculomotor apraxia, and various neurological manifestations. Early and accurate genetic diagnosis is essential for proper disease management, prognosis assessment, and family planning decisions.

What This Advanced Genetic Test Detects

This comprehensive Next-Generation Sequencing (NGS) test specifically analyzes the APTX (aprataxin) gene to identify pathogenic variants responsible for AOA1. The test examines:

  • Complete coding regions of the APTX gene
  • Exon-intron boundaries for splice site mutations
  • Known pathogenic variants and novel mutations
  • Copy number variations affecting gene function
  • Sequence variations impacting protein structure and function

Who Should Consider This Genetic Test

This test is recommended for individuals presenting with symptoms suggestive of AOA1 or those with a family history of neurological disorders. Key indications include:

  • Progressive cerebellar ataxia beginning in childhood or early adulthood
  • Oculomotor apraxia (difficulty moving eyes voluntarily)
  • Choreoathetosis (involuntary movements)
  • Peripheral neuropathy with sensory and motor involvement
  • Cognitive impairment or learning difficulties
  • Family history of similar neurological symptoms
  • Consanguineous parents with neurological concerns
  • Unexplained progressive coordination difficulties

Significant Benefits of Genetic Testing

Undergoing APTX gene testing provides numerous advantages for patients and families:

  • Accurate Diagnosis: Confirms or rules out AOA1 with high precision
  • Early Intervention: Enables timely management strategies
  • Family Planning: Provides crucial information for reproductive decisions
  • Prognostic Information: Helps predict disease progression and outcomes
  • Targeted Management: Guides appropriate therapeutic approaches
  • Genetic Counseling: Supports informed decision-making for family members
  • Research Contribution: Advances understanding of rare neurological disorders

Understanding Your Test Results

Our comprehensive genetic report provides clear interpretation of your results with clinical context:

  • Positive Result: Identifies pathogenic variants in the APTX gene, confirming AOA1 diagnosis and enabling appropriate management
  • Negative Result: No pathogenic variants detected, though clinical correlation remains essential
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical evaluation
  • Carrier Status: Identifies individuals with one mutated copy who may pass the condition to offspring

All results include detailed explanations and recommendations for follow-up care with neurologists and genetic counselors.

Test Details and Pricing

Test Component Details
Test Name APTX Gene Ataxia-Oculomotor Apraxia Type 1 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Neurology & Genetics

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session before testing
  • Family pedigree chart development
  • Neurological examination records
  • Informed consent for genetic testing

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Neurological Health

Don’t let uncertainty about neurological symptoms affect your quality of life. Early genetic diagnosis of APTX gene mutations can provide clarity, guide treatment decisions, and offer peace of mind for you and your family. Our expert team of genetic counselors and neurologists is ready to support you through every step of the testing process.

Ready to schedule your APTX Gene Ataxia-Oculomotor Apraxia Type 1 NGS Genetic DNA Test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and accessing personalized neurological care.